著者 |
キムラ, ユウイチ
イズミヤ, ヤスヒロ
アラキ, サトシ
ヤマムラ, サトル
ハナタニ, シンスケ
オノウエ, ヨシロウ
イシダ, トシフミ
アリマ, ユウイチロウ
ナカムラ, タイシ
ヤマモト, エイイチロウ
セノクチ, タカフミ
ヨシザワ, タツヤ
佐田, 政隆
キム ミツヤマ, ショウケイ
ナカガタ, ナオミ
Bober, Eva
Braun, Thomas
カイキタ, コウイチ
ヤマガタ, カズヤ
ツジタ, ケンイチ
|
|
内容記述 |
Background: Sirt7 is a recently identified sirtuin and has important roles in various pathological conditions, including cancer progression and metabolic disorders. It has previously been reported that Sirt7 is a key molecule in acute myocardial wound healing and pressure overload-induced cardiac hypertrophy. In this study, the role of Sirt7 in neointimal formation after vascular injury is investigated. Methods and Results: Systemic (Sirt7−/−) and smooth muscle cell-specific Sirt7-deficient mice were subjected to femoral artery wire injury. Primary vascular smooth muscle cells (VSMCs) were isolated from the aorta of wild type (WT) and Sirt7−/−mice and their capacity for cell proliferation and migration was compared. Sirt7 expression was increased in vascular tissue at the sites of injury. Sirt7−/−mice demonstrated significant reduction in neointimal formation compared to WT mice. In vitro, Sirt7 deficiency attenuated the proliferation of serum-induced VSMCs. Serum stimulation-induced upregulation of cyclins and cyclin-dependent-kinase 2 (CDK2) was significantly attenuated in VSMCs of Sirt7−/−compared with WT mice. These changes were accompanied by enhanced expression of the microRNA 290-295 cluster, the translational negative regulator of CDK2, in VSMCs of Sirt7−/−mice. It was confirmed that smooth muscle cell-specific Sirt7-deficient mice showed significant reduction in neointima compared with control mice. Conclusions: Sirt7 deficiency attenuates neointimal formation after vascular injury. Given the predominant role in vascular neointimal formation, Sirt7 is a potentially suitable target for treatment of vascular diseases. |